Effect of Admixture of Commercially Available Corticosteroid Ointments and/or Creams on Vasoconstrictor Activity

Yakugaku Zasshi

Volumn 122, Issue 1, 2002, Pages 107-112

  Ohtani, Michiteru ^a   Yamada, Nobuo ^b   Takayama, Kazuo ^c   Kotaki, Hajime ^d   Etoh, Takafumi ^a   Kariya, Satoru ^a   Uchino, Katsuyoshi ^a   Iga, Tatsuji ^c  

^a Tokyo Postal Services Agency Hospital   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

admixture; corticosteroids; skin permeability; stability; vasoconstrictor activity

Indexed keywords

CORTICOSTEROID; HEPARINOID; UREA;

ADULT; ANIMAL; ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; DRUG STABILITY; EMULSION; FEMALE; HAIRLESS MOUSE; HUMAN; MALE; METABOLISM; MOUSE; OINTMENT; SKIN; SKIN ABSORPTION; VASCULARIZATION; VASOCONSTRICTION;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; CELL MEMBRANE PERMEABILITY; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG STABILITY; EMULSIONS; FEMALE; HEPARINOIDS; HUMANS; MALE; MICE; MICE, INBRED HRS; OINTMENTS; SKIN; SKIN ABSORPTION; UREA; VASOCONSTRICTION;

EID: 0036363659     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.122.107     Document Type: Article

References (14)

1. Tokyo Organization of Dermatology., J. Jpn. Organi. Clin. Dermatol., 38, November, 176-199 (1993).
2. Etoh T., Clin. Dermatol., 55, 96-101 (2001).
3. Ministry of Health, Labour and Welfare., A Guideline for The Treatment of Atopic Dermatitis 2001.
4. Ohishi T., Shinagawa R., Harada Y., Nagatani K., Nasu K., J. Jpn. Soc. Hosp. Pharm., 27, 39-47 (1991).
5. Ohishi T., Shinagawa R., Harada Y., Takebayashi Y., Nasu K., J. Jpn. Soc. Hosp. Pharm., 28, 93-100 (1992).
6. Ohishi T., Shinagawa R., Okazaki Y., Tanabe T., J. Jpn. Soc. Hosp. Pharm., 29, 91-100 (1993).
7. Itobe H., Inoue N., Kusunoki M., Kobayashi D., Kimura M., Ishijima S., Natsume H., Sugibayashi K., Morimoto Y., Yakuzaigaku, 53, 242-248 (1993).
8. Ohtani M., Sakuma H., Takayama K., Kotaki H., Sawada Y., Iga T., Jpn. J. Hosp. Pharm., 23, 11-18 (1997).
9. McKenzie A., Stoughton R., Arch. Derm., 86, 608-610 (1962).
10. Ohtani M., Yokoyama M., Kotaki H., Sawada Y., Iga T., Jpn. J. Hosp. Pharm., 19, 493-502 (1993).
11. Ishihara M., The Nishinihon Clin. Dermatol., 37, 86-95 (1975).
12. Sakurada K, Ozaki S, Kogori A, Sugawara K., Jpn. J. Hosp. Pharm., 13, 340 (1987).
13. Dick I. P., Scott R. C., J. Pharm. Pharmacol., 44, 640-645 (1992).
14. Morimoto Y., Hatanaka T., Sugibayashi K., Omiya H., J. Pharm. Pharmacol., 44, 634-639 (1992).